ROBERT R. RUFFOLO

Insider Reports History

Location
Madison, NJ
Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROBERT R. RUFFOLO:

Company Role Class Num Shares Value Price $ Report Date Ownership
LB PHARMACEUTICALS INC Director Stock Option (Right to Buy) 22,449 10 Sep 2025 Direct
Aridis Pharmaceuticals, Inc. Director Restricted Stock Units 10,000 05 Dec 2022 Direct
Elicio Therapeutics, Inc. Director Stock Option (Right to Buy) 7,900 19 May 2025 Direct
LB PHARMACEUTICALS INC Director Common Stock 2,365 10 Sep 2025 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.7500 11 Aug 2023 Direct

Insider Reports Filed by ROBERT R. RUFFOLO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 7 $0 4 Director 12 Sep 2025, 18:25
LBRX LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 Director 10 Sep 2025, 19:20
ELTX Elicio Therapeutics, Inc. 19 May 2025 1 $0 4 Director 20 May 2025, 16:06
ELTX Elicio Therapeutics, Inc. 21 Nov 2024 1 $0 4 Director 25 Nov 2024, 07:34
ELTX Elicio Therapeutics, Inc. 28 Dec 2023 1 $0 4 Director 29 Dec 2023, 17:05
SGTX Sigilon Therapeutics, Inc. 11 Aug 2023 3 -$36,144 4 Director 11 Aug 2023, 16:10
ELTX Elicio Therapeutics, Inc. 01 Jun 2023 0 $0 3 Director 07 Jun 2023, 21:48
SGTX Sigilon Therapeutics, Inc. 19 May 2023 1 $0 4 Director 22 May 2023, 16:20
ARDS Aridis Pharmaceuticals, Inc. 05 Dec 2022 1 $0 4 Director 07 Dec 2022, 08:01
SGTX Sigilon Therapeutics, Inc. 26 May 2022 1 $0 4 Director 27 May 2022, 17:00
ARDS Aridis Pharmaceuticals, Inc. 04 Oct 2021 1 $0 4 Director 05 Oct 2021, 18:51
SGTX Sigilon Therapeutics, Inc. 01 Jul 2021 3 -$66,082 4 Director 02 Jul 2021, 16:16
SGTX Sigilon Therapeutics, Inc. 24 Jun 2021 1 +$88,613 4 Director 28 Jun 2021, 07:15